News Focus
News Focus
Followers 43
Posts 5674
Boards Moderated 1
Alias Born 02/17/2006

Re: lmf1264 post# 177070

Monday, 03/24/2008 1:45:47 PM

Monday, March 24, 2008 1:45:47 PM

Post# of 203990
There was no point in persuing generic paclataxel because the market has been flooded by cheap chinese supply. This was a prudent move by the company. On another front though there seems to be a lot of evidence that Xechem is actively engaged in NIPRD's project to produce domestic artemsia based anti-malarials. Without the plant extraction processes developed by Xechem and instituted by NIPRD they wouldn't be as far along as they are.

One head cannot contain all wisdom.

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today